Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow COR
Cencora, Inc. (COR) EV/FCF
As of 16 October 2026, Cencora, Inc. (COR) trades at a EV/FCF of 18.2×. Over the past ten years it has ranged from −91.3× (March 2025) to 57.6× (September 2025); the current reading is higher than 81% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 19.9× | 29.98% |
| FY2024 | 15.3× | 37.58% |
| FY2023 | 11.1× | (19.48%) |
| FY2022 | 13.8× | 7.28% |
| FY2021 | 12.9× | 24.74% |
| FY2020 | 10.3× | 14.20% |
| FY2019 | 9.1× | (56.20%) |
| FY2018 | 20.7× | 9.72% |
| FY2017 | 18.8× | 171.03% |
| FY2016 | 7.0× | 41.56% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 15.5× | (65.23%) |
| Mar 2026 | 44.5× | 126.47% |
| Dec 2025 | 19.7× | (1.29%) |
| Sep 2025 | 19.9× | (64.54%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| ACH Accendra Health, Inc. compare | −11.0× |
| FOCL FocalTherics compare | −8.7× |
| COSM Cosmos Health Inc. compare | −2.3× |
| AHG Akso Health Group Sponsored ADR compare | −0.2× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 5.0× |
| CAH Cardinal Health, Inc. compare | 14.0× |
| COR Cencora, Inc. | 18.2× |
| MCK McKesson Corporation compare | 21.0× |
| HSIC Henry Schein, Inc. compare | 21.2× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement